KR940702156A - 신규의 킬레이트화제, 상기 킬레이트화제와 금속 원자로 구성된 착 화합물, 및 상기 화합물을 포함하는 진단제(novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound) - Google Patents
신규의 킬레이트화제, 상기 킬레이트화제와 금속 원자로 구성된 착 화합물, 및 상기 화합물을 포함하는 진단제(novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound)Info
- Publication number
- KR940702156A KR940702156A KR1019940700696A KR19940700696A KR940702156A KR 940702156 A KR940702156 A KR 940702156A KR 1019940700696 A KR1019940700696 A KR 1019940700696A KR 19940700696 A KR19940700696 A KR 19940700696A KR 940702156 A KR940702156 A KR 940702156A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- salt
- agent
- complex compound
- metal atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
본 발명은 하기 일반식(I)로 표시되는 화합물, 상기 화합물과 금속 원자로 구성되는 착 화합물 및 상기 착 화합물을 포함하는 진단제에 관한 것으로서, 상기 언급한 화합물(I)은 킬레이트화제로서 유용하며 착 화합물은 영상 진단을 위한 대비 매질로서 보다 우수한 특성을 나타낸다.
상기 식중에서, m은 1 내지 3의 정수이고; R1및 R2는 동일 또는 상이하며 각각 수소 원자 또는 저급 알킬이고; R3, R4, R5및 R6은 동일 또는 상이하며 각각 히드록시 또는 하기 일반식(Ⅱ),
의 기이고(상기 식중에서, n은 0 또는 1이고; X는 -NH- 또는 -O-이며; Y는 알킬렌이고; A는 수소 원자, 저급 알킬, 저급 알콕시, 할로겐 원자 또는 트리플루오로메틸이며; B는 알킬 또는 알케닐이다); 단, R3, R4, R5및 R6중 둘 또는 세개의 히드록실기이며, 이들중 두개가 히드록실기인 경우, R3및 R5가 히드록시이고, R4및 R6이 히드록시인 경우는 배제된다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 킬레이트화제 및 금속 원자를 포함하는 본 발명의 착 화합물을 쥐에게 투여하는 경우, 상기 화합물의 기관(간장, 신장 또는 비장)내에서의 축적도를 도시한 것이다.
Claims (12)
- 하기 일반식(I)의 화합물 :상기 식중에서, m은 1 내지 3의 정수이고; R1및 R2는 동일 또는 상이하며 각각 수소 원자 또는 저급 알킬이고; R3, R4, R5및 R6은 동일 또는 상이하며 각각 히드록시 또는 하기 일반식,의 기이고(상기 식중에서, n은 0 또는 1이고; X는 -NH- 또는 -O-이며; Y는 알킬렌이고; A는 수소 원자, 저급 알킬, 저급 알콕시, 할로겐 원자 또는 트리플루오로메틸이며; B는 알킬 또는 알케닐이다); 단, R3, R4, R5및 R6중 둘 또는 세개의 히드록실기이며, 이들중 두개가 히드록실기인 경우, R3및 R5가 히드록시이고, R4및 R6이 히드록시인 경우는 배제된다.
- 제1항에 있어서, 상기 일반식(I)에서, Y 및 B의 전체 탄소수가 8-12이거나, 또는 이것의 염인 화합물.
- 제1항에 있어서, 상기 일반식(I)에서, B가 Y에 대해 메타- 또는 파라 위치에서 결합되거나, 또는 이것의 염인 화합물.
- 제1항에 있어서, N-(4-헥실페닐카르바모일메틸)디에틸렌트리아민-N,N',N",N"-테트라아세트산, N-(4-옥틸페닐카르바모일메틸)디에틸렌트리아민-N,N',N",N"-테트라아세트산, N-(4-데실페닐카르바모일메틸)디에틸렌트리아민-N,N',N",N"-테트라아세트산, 및 N-(4-도데실페닐카르바모일메틸)디에틸렌트리아민-N,N',N",N"-테트라아세트산, 또는 이들의 염으로 구성되는 군에서 선택되는 화합물.
- 제1항의 화합물 및 금속 원자, 또는 이들의 염을 포함하는 착 화합물.
- 제5항에 있어서, 상기 금속 원자가 상자성 금속 원자이거나, 또는 이것의 염인 착 화합물.
- 제6항에 있어서, 상기 금속 원자가 가돌리늄(Ⅲ), 테르븀(Ⅲ), 디스프로슘(Ⅲ), 홀뮴(Ⅲ), 에르븀(Ⅲ) 및 철(Ⅲ)로 구성되는 군에서 선택되는 착화합물.
- 제5항의 착 화합물 또는 이것의 염을 포함하는 약학적 조성물.
- 제8항에 있어서, 진단제인 조성물.
- 제1항의 화합물 및 상자성 금속 원자를 포함하는 착 화합물, 또는 이것의 염을 포함하는, 동맥 경화증에 대한 진단제.
- 제1항의 화합물과 상자성 금속 원자의 착 화합물, 또는 이것의 염을 포함하는, 간장 종양에 대한 진단제.
- 제1항의 화합물 및 금속 원자를 포함하는 착 화합물, 또는 이것의 염을 잠재 질병을 갖는 환자에게 투여하여, 장해를 영상화하는 것을 포함하는 영상 진단 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20328291 | 1991-07-18 | ||
JP4200392A JP2807852B2 (ja) | 1991-07-18 | 1992-07-03 | 新規キレート化剤、該キレート化剤と金属原子との錯化合物及びそれを含む診断剤 |
JP92-200392 | 1992-07-03 | ||
PCT/JP1993/000331 WO1994001393A1 (en) | 1992-07-03 | 1993-03-22 | Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound |
Publications (2)
Publication Number | Publication Date |
---|---|
KR940702156A true KR940702156A (ko) | 1994-07-28 |
KR100251427B1 KR100251427B1 (ko) | 2000-05-01 |
Family
ID=26512160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940700696A KR100251427B1 (ko) | 1991-07-18 | 1993-03-22 | 신규의 킬레이트제, 상기 킬레이트제와 금속 원자의 착 화합물, 및 상기 화합물을 포함하는 진단제 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2807852B2 (ko) |
KR (1) | KR100251427B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4863648A (en) * | 1986-07-03 | 1989-09-05 | Rutgers, The State University Of New Jersey | Process for making polarized material |
TW213864B (ko) * | 1991-08-01 | 1993-10-01 | Squibb & Sons Inc | |
CA2116867C (en) * | 1992-07-03 | 2004-04-27 | The Green Cross Corporation | Novel chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL83966A (en) * | 1986-09-26 | 1992-03-29 | Schering Ag | Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them |
JP2776953B2 (ja) * | 1990-04-10 | 1998-07-16 | 日本メジフィジックス株式会社 | 多官能性金属キレート化合物とその用途 |
-
1992
- 1992-07-03 JP JP4200392A patent/JP2807852B2/ja not_active Expired - Fee Related
-
1993
- 1993-03-22 KR KR1019940700696A patent/KR100251427B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPH05229998A (ja) | 1993-09-07 |
JP2807852B2 (ja) | 1998-10-08 |
KR100251427B1 (ko) | 2000-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960702447A (ko) | 간담용 자기공명 콘트라스트제(hepatobiliary magnetic resonance contrast agents) | |
US4760173A (en) | NMR contrast agents | |
US5330743A (en) | Aminosaccharide contrast agents for magnetic resonance images | |
US5804161A (en) | Contrast agents | |
US5746995A (en) | DTPA derivatives substituted in a novel way, their metal complexes, and their use in diagnosis and therapy | |
US5466439A (en) | Polymeric contrast enhancing agents for magnetic resonance images | |
EP0436579B1 (en) | Chelate compositions | |
WO1996014878A3 (en) | Calixarene conjugates useful as MRI and CT diagnostic imaging agents | |
DK297383A (da) | Fremgangsmaade til fremstilling af piperazinderivater | |
JPH05503072A (ja) | 診断用nmr映像化の為のヒドロキシ―アリール金属キレート | |
KR950701231A (ko) | 카복스아미드 변성된 폴리아민 킬레이트제 및 방사성 착화합물 및 결합체(carboxamide modified polyamine chelators and radioactive complexes and conjugates) | |
US5409689A (en) | MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms | |
EP0603403B2 (en) | Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound | |
RU93005056A (ru) | Новое диаминовое соединение и церебральное защитное лекарственное средство на его основе | |
KR910018346A (ko) | 킬레이트화 화합물 및 그의 용도 | |
JPH09507668A (ja) | イメージング用官能化大環状配位子類 | |
US6117412A (en) | Non-cluster type bismuth compounds | |
CA2179624A1 (en) | Metal complexes of dendrimeric molecules, diagnostic agents containing them and process for producing the complexes and agents | |
KR900006273A (ko) | 오르토 결합 작용기를 갖는 킬란트 및 그의 착물 | |
KR940702156A (ko) | 신규의 킬레이트화제, 상기 킬레이트화제와 금속 원자로 구성된 착 화합물, 및 상기 화합물을 포함하는 진단제(novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound) | |
CA2110815A1 (en) | Novel compositions for magnetic resonance imaging | |
US5616312A (en) | Thiol ligands and complexes for X-ray imaging | |
US5463030A (en) | Metal chelating agents for medical application | |
US5869025A (en) | Tripodal aromatic heterocycle carboxamide MRI contrast agents | |
US5869026A (en) | Tripodal carboxamide ligands for MRI contrast agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20041228 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |